Description
A selective inhibitor of CYP3A4 (IC50 = 0.011 µM); highly selective for CYP3A4 over CYP3A5 (IC50 = 33 µM); inhibits metabolism of midazolam to 1’-hydroxy midazolam, testosterone to 6β-hydroxy testosterone, and vincristine to vincristine M1 in HLMs expressing CYP3A4 (IC50s = 9, 4, and 38 nM, respectively) but not those expressing CYP3A5; decreases lapatinib-induced quinoneimine-glutathione adduct formation in HLMs by 78% at 2.5 µM
Formal name: N-(4′-cyano[1,1′-biphenyl]-4-yl)-N’-[4-(3H-imidazo[4,5-b]pyridin-7-yl)phenyl]-urea
Synonyms:
Molecular weight: 430.5
CAS: 1361414-26-7
Purity: ≥95%
Formulation: A solid
Product Type|Biochemicals|Small Molecule Inhibitors|Cytochrome P450||Product Type|Biochemicals|Small Molecule Inhibitors|MMPs||Research Area|Toxicology|Drug Metabolism|Cytochrome P450